|
羧基-PEG5-磺酸
|
C597001-250mg
|
≥95% |
1817735-38-8 |
250mg
|
¥ 11549.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
羧基-PEG5-磺酸
|
C597001-1g
|
≥95% |
1817735-38-8 |
1g
|
¥ 27300.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
羧基-PEG5-磺酸
|
C597001-100mg
|
≥95% |
1817735-38-8 |
100mg
|
¥ 7139.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
羧基-PEG4-磺酸
|
C597000-500mg
|
≥98% |
1817735-25-3 |
500mg
|
¥ 8966.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
羧基-PEG4-磺酸
|
C597000-250mg
|
≥98% |
1817735-25-3 |
250mg
|
¥ 6724.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
羧基-PEG4-磺酸
|
C597000-1g
|
≥98% |
1817735-25-3 |
1g
|
¥ 11955.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
羧基-PEG4-磺酸
|
C597000-100mg
|
≥98% |
1817735-25-3 |
100mg
|
¥ 5042.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
羧基-PEG2-磺酸
|
C596999-500mg
|
≥98% |
1817735-45-7 |
500mg
|
¥ 16380.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
羧基-PEG2-磺酸
|
C596999-250mg
|
≥98% |
1817735-45-7 |
250mg
|
¥ 10920.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
羧基-PEG2-磺酸
|
C596999-1g
|
≥98% |
1817735-45-7 |
1g
|
¥ 19426.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
羧基-PEG2-磺酸
|
C596999-100mg
|
≥98% |
1817735-45-7 |
100mg
|
¥ 6720.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Cbz-N-酰胺基-PEG4-酸
|
C596995-500mg
|
≥98% |
756526-00-8 |
500mg
|
¥ 3780.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Cbz-N-酰胺基-PEG4-酸
|
C596995-2g
|
≥98% |
756526-00-8 |
2g
|
¥ 11025.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Cbz-N-酰胺基-PEG4-酸
|
C596995-1g
|
≥98% |
756526-00-8 |
1g
|
¥ 7350.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-((2,5-二氧基-2,5-二氢-1h-吡咯-1-基)甲基)-n-(2-丙炔-1-基)环己烷甲酰胺
|
C596945-5g
|
≥98% |
1036847-90-1 |
5g
|
¥ 2735.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-((2,5-二氧基-2,5-二氢-1h-吡咯-1-基)甲基)-n-(2-丙炔-1-基)环己烷甲酰胺
|
C596945-500mg
|
≥98% |
1036847-90-1 |
500mg
|
¥ 330.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-((2,5-二氧基-2,5-二氢-1h-吡咯-1-基)甲基)-n-(2-丙炔-1-基)环己烷甲酰胺
|
C596945-1g
|
≥98% |
1036847-90-1 |
1g
|
¥ 549.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
{2-[(4-{[双-(2-叔丁氧基羰基氨基-乙基)-氨基]-甲基}-苄基)-(2-叔丁氧基羰基氨基-乙基)-氨基]-乙基}-氨基甲酸叔-丁酯
|
C596939-500mg
|
≥96% |
1807521-06-7 |
500mg
|
¥ 10944.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
{2-[(4-{[双-(2-叔丁氧基羰基氨基-乙基)-氨基]-甲基}-苄基)-(2-叔丁氧基羰基氨基-乙基)-氨基]-乙基}-氨基甲酸叔-丁酯
|
C596939-1g
|
≥96% |
1807521-06-7 |
1g
|
¥ 21779.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
{2-[(4-{[双-(2-叔丁氧基羰基氨基-乙基)-氨基]-甲基}-苄基)-(2-叔丁氧基羰基氨基-乙基)-氨基]-乙基}-氨基甲酸叔-丁酯
|
C596939-100mg
|
≥96% |
1807521-06-7 |
100mg
|
¥ 2199.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Cy3甲基四嗪
|
C596625-5mg
|
≥98% |
2183473-57-4 |
5mg
|
¥ 6090.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Cy3甲基四嗪
|
C596625-50mg
|
≥98% |
2183473-57-4 |
50mg
|
¥ 26250.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Cy3甲基四嗪
|
C596625-25mg
|
≥98% |
2183473-57-4 |
25mg
|
¥ 14280.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Cy7炔烃
|
C596618-5mg
|
≥95% |
1998119-13-3 |
5mg
|
¥ 4200.9
|
期货,请咨询 |
|
0 |
阿拉丁 |